Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis-Reference-Cited by-同舟云学术

Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis

Published:2013-10 Issue:44 Volume:17 Page:
ISSN:1366-5278
Container-title:Health Technol Assess
language:en
Short-container-title:

Author:

Ward S¹,Scope A,Rafia R,Pandor A,Harnan S,Evans P,Wyld L

Affiliation:

1. School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK

Funder

National Institute for Health Research

Publisher

National Institute for Health Research

Subject

Health Policy

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation Between Oncotype Dx Recurrence Score and PREDICT Estimates in Early Breast Cancer: A Single Institution Experience;JCO Global Oncology;2024-08

2. aiGeneR 1.0: An Artificial Intelligence Technique for the Revelation of Informative and Antibiotic Resistant Genes in Escherichia coli;Frontiers in Bioscience-Landmark;2024-02-22

3. The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience;Genes;2023-08-28

4. Cost-utility analysis of genomic profiling in early breast cancer in Colombia;Cost Effectiveness and Resource Allocation;2023-07-10

5. The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX® Testing;Cancers;2023-01-31